• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人脐带血干细胞上调脊髓损伤大鼠的基质金属蛋白酶-2

Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury.

作者信息

Veeravalli Krishna Kumar, Dasari Venkata Ramesh, Tsung Andrew J, Dinh Dzung H, Gujrati Meena, Fassett Dan, Rao Jasti S

机构信息

Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.

出版信息

Neurobiol Dis. 2009 Oct;36(1):200-12. doi: 10.1016/j.nbd.2009.07.012. Epub 2009 Jul 23.

DOI:10.1016/j.nbd.2009.07.012
PMID:19631747
Abstract

Matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes involved in inflammation, wound healing and other pathological processes after neurological disorders. MMP-2 promotes functional recovery after spinal cord injury (SCI) by regulating the formation of a glial scar. In the present study, we aimed to investigate the expression and/or activity of several MMPs, after SCI and human umbilical cord blood mesenchymal stem cell (hUCB) treatment in rats with a special emphasis on MMP-2. Treatment with hUCB after SCI altered the expression of several MMPs in rats. MMP-2 is upregulated after hUCB treatment in spinal cord injured rats and in spinal neurons injured either with staurosporine or hydrogen peroxide. Further, hUCB induced upregulation of MMP-2 reduced formation of the glial scar at the site of injury along with reduced immunoreactivity to chondroitin sulfate proteoglycans. Blockade of MMP-2 activity in hUCB cocultured injured spinal neurons reduced the protection offered by hUCB which indicated the involvement of MMP-2 in the neuroprotection offered by hUCB. Based on these results, we conclude that hUCB treatment after SCI upregulates MMP-2 levels and reduces the formation of the glial scar thereby creating an environment suitable for endogenous repair mechanisms.

摘要

基质金属蛋白酶(MMPs)是一类庞大的蛋白水解酶家族,参与炎症、伤口愈合及神经功能紊乱后的其他病理过程。MMP-2通过调节胶质瘢痕的形成促进脊髓损伤(SCI)后的功能恢复。在本研究中,我们旨在调查大鼠SCI及人脐带血间充质干细胞(hUCB)治疗后几种MMPs的表达和/或活性,特别关注MMP-2。SCI后用hUCB治疗改变了大鼠几种MMPs的表达。脊髓损伤大鼠以及用星形孢菌素或过氧化氢损伤的脊髓神经元经hUCB治疗后,MMP-2表达上调。此外,hUCB诱导的MMP-2上调减少了损伤部位胶质瘢痕的形成,同时降低了对硫酸软骨素蛋白聚糖的免疫反应性。在与hUCB共培养的损伤脊髓神经元中阻断MMP-2活性会降低hUCB提供的保护作用,这表明MMP-2参与了hUCB提供的神经保护作用。基于这些结果,我们得出结论,SCI后用hUCB治疗可上调MMP-2水平并减少胶质瘢痕的形成,从而创造一个适合内源性修复机制的环境。

相似文献

1
Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury.人脐带血干细胞上调脊髓损伤大鼠的基质金属蛋白酶-2
Neurobiol Dis. 2009 Oct;36(1):200-12. doi: 10.1016/j.nbd.2009.07.012. Epub 2009 Jul 23.
2
Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells.人脐带间充质干细胞移植治疗急性创伤性脊髓损伤的功能恢复。
Crit Care Med. 2010 Nov;38(11):2181-9. doi: 10.1097/CCM.0b013e3181f17c0e.
3
Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury.软骨素酶ABC联合神经干细胞/祖细胞移植可促进大鼠脊髓损伤后移植细胞的迁移以及生长相关蛋白43阳性纤维的生长。
Eur J Neurosci. 2005 Dec;22(12):3036-46. doi: 10.1111/j.1460-9568.2005.04492.x.
4
Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats.人脐带血或羊膜上皮干细胞移植可缓解大鼠脊髓损伤后的机械性痛觉过敏。
Cell Transplant. 2013;22(9):1577-90. doi: 10.3727/096368912X659907. Epub 2013 Jan 2.
5
Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors.人脐带血来源的CD34+细胞可通过刺激血管内皮生长因子和神经营养因子来减轻脊髓损伤。
Shock. 2008 Jan;29(1):49-55. doi: 10.1097/shk.0b013e31805cddce.
6
Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study.人骨髓基质细胞和单核细胞骨髓细胞移植入损伤的脊髓:一项比较研究。
Spine (Phila Pa 1976). 2009 Nov 15;34(24):2605-12. doi: 10.1097/BRS.0b013e3181bdca87.
7
Neuroprotection by cord blood stem cells against glutamate-induced apoptosis is mediated by Akt pathway.脐带血干细胞对谷氨酸诱导的细胞凋亡的神经保护作用是由Akt信号通路介导的。
Neurobiol Dis. 2008 Dec;32(3):486-98. doi: 10.1016/j.nbd.2008.09.005. Epub 2008 Sep 30.
8
Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury.基质金属蛋白酶-2促进脊髓损伤后促进功能恢复的伤口愈合过程。
J Neurosci. 2006 Sep 27;26(39):9841-50. doi: 10.1523/JNEUROSCI.1993-06.2006.
9
Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.皮质发育过程中的蛋白水解活性与缺氧缺血性损伤中涉及的蛋白水解活性不同。
Neuroscience. 2009 Jan 23;158(2):732-44. doi: 10.1016/j.neuroscience.2008.07.069. Epub 2008 Aug 14.
10
Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury.人脐带血源间充质干细胞移植后犬急性脊髓损伤的雪旺细胞样髓鞘再生。
J Neurol Sci. 2011 Jan 15;300(1-2):86-96. doi: 10.1016/j.jns.2010.09.025. Epub 2010 Nov 10.

引用本文的文献

1
Evaluation of single-dose umbilical cord blood-derived mononuclear cell injection immediately and 7 days after spinal cord trauma in mice.小鼠脊髓损伤后即刻及7天时单剂量脐血来源单个核细胞注射的评估
Clinics (Sao Paulo). 2025 Jan 30;80:100579. doi: 10.1016/j.clinsp.2025.100579. eCollection 2025.
2
Progression of mesenchymal stem cell regulation on imbalanced microenvironment after spinal cord injury.脊髓损伤后间充质干细胞对失衡微环境的调节进展
Stem Cell Res Ther. 2024 Oct 1;15(1):343. doi: 10.1186/s13287-024-03914-x.
3
Efficacy of growth factor gene-modified stem cells for motor function after spinal cord injury in rodents: a systematic review and meta‑analysis.
生长因子基因修饰干细胞治疗脊髓损伤后运动功能的疗效:系统评价和荟萃分析。
Neurosurg Rev. 2024 Feb 19;47(1):87. doi: 10.1007/s10143-024-02314-2.
4
Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects.基于多能间充质干细胞的脊髓损伤治疗:当前进展与未来展望
Biology (Basel). 2023 Apr 26;12(5):653. doi: 10.3390/biology12050653.
5
Reviving the use of inhibitors of matrix metalloproteases in spinal cord injury: a case for specificity.恢复基质金属蛋白酶抑制剂在脊髓损伤中的应用:特异性的考量
Neural Regen Res. 2023 Sep;18(9):1925-1930. doi: 10.4103/1673-5374.367837.
6
Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration.基质金属蛋白酶-12抑制对缺血性中风后神经功能恢复的治疗效果:最佳治疗时机和持续时间
Front Neurosci. 2022 Oct 4;16:1012812. doi: 10.3389/fnins.2022.1012812. eCollection 2022.
7
Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury.间充质干细胞(MSCs)及其衍生的细胞外囊泡在脊髓损伤治疗中的治疗潜力。
Int J Mol Sci. 2021 Dec 20;22(24):13672. doi: 10.3390/ijms222413672.
8
Stem Cell Therapy for Spinal Cord Injury.脊髓损伤的干细胞治疗。
Cell Transplant. 2021 Jan-Dec;30:963689721989266. doi: 10.1177/0963689721989266.
9
MiR-19b-3p accelerates bone loss after spinal cord injury by suppressing osteogenesis via regulating PTEN/Akt/mTOR signalling.miR-19b-3p 通过调控 PTEN/Akt/mTOR 信号通路抑制成骨作用从而加速脊髓损伤后的骨丢失。
J Cell Mol Med. 2021 Jan;25(2):990-1000. doi: 10.1111/jcmm.16159. Epub 2020 Dec 17.
10
Stimuli-Responsive Delivery of Growth Factors for Tissue Engineering.用于组织工程的生长因子的刺激响应性递送
Adv Healthc Mater. 2020 Apr;9(7):e1901714. doi: 10.1002/adhm.201901714. Epub 2020 Mar 3.